Lineage Cell Therapeutics In shares owned by Oxford Financial
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Oxford Financial
from 13F filings
Historical chart of Oxford Financial investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Oxford Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Oxford Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $15k | 13k | 1.18 |
| 2023-06-30 | $18k | 13k | 1.41 |
| 2023-03-31 | $19k | 13k | 1.50 |
| 2022-12-31 | $15k | 13k | 1.17 |
| 2022-09-30 | $14k | 13k | 1.11 |
| 2022-06-30 | $20k | 13k | 1.58 |
| 2022-03-31 | $19k | 13k | 1.50 |
| 2021-12-31 | $31k | 13k | 2.45 |
| 2021-09-30 | $32k | 13k | 2.53 |
| 2021-06-30 | $36k | 13k | 2.85 |
| 2021-03-31 | $30k | 13k | 2.38 |
| 2020-12-31 | $22k | 13k | 1.74 |